Axsome Therapeutics, Inc. (AXSM)
184.02
-0.16
(-0.09%)
USD |
NASDAQ |
Apr 16, 16:00
184.02
0.00 (0.00%)
After-Hours: 18:49
Axsome Therapeutics Cash from Investing (Quarterly) : -0.071M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Madrigal Pharmaceuticals, Inc. | 27.58M |
| Amicus Therapeutics, Inc. | -6.494M |
| Insmed, Inc. | 389.41M |
| MannKind Corp. | -291.96M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.65M |
| Cash from Financing (Quarterly) | 16.38M |
| Free Cash Flow | -93.88M |
| Free Cash Flow Per Share (Quarterly) | -0.3698 |
| Free Cash Flow to Equity (Quarterly) | -18.24M |
| Free Cash Flow to Firm (Quarterly) | -15.47M |
| Free Cash Flow Yield | -1.03% |